Virtual Network's Login.
About the Conference:
ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives.
The presentation of unpublished data is encouraged.
This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.
CONFERENCE MAIN SCIENTIFIC TOPICS:
- Biology of diffuse large B cell lymphoma subtypes II
- Novel molecular lymphoma subtypes
- Epigenetic and genetic regulation of clonal lymphoma evolution
- Lymphoma cell interactions in the tumor microenvironment
- Monoclonal antibodies & non-cellular immune therapies
- Cellular immune therapies
- Small molecular pathway inhibitors
- Combination therapies
- Use of CT DNA for diagnostic and therapeutic monitoring
With the support of*:
Premium Conference Partner
*******
Emerald Conference Partners
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
